Metrics to compare | 363250 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship363250PeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.6x | −5.8x | −0.4x | |
PEG Ratio | 0.08 | −0.17 | 0.00 | |
Price/Book | 3.2x | 1.6x | 2.6x | |
Price / LTM Sales | 47.5x | 3.9x | 2.9x | |
Upside (Analyst Target) | - | 57.8% | 58.0% | |
Fair Value Upside | Unlock | 18.0% | 9.5% | Unlock |
Genesystem Co., Ltd., a biotech engineering company, specializes in molecular testing solutions to target on-site testing needs. The company offers PCR systems, multiplex biochips, and PCR reagents. It also provides human pathogen assays, including novel coronavirus (SARS-CoV-2) detection kits, SARS-CoV-2/Flu/RSV simultaneous detection kits, and mycobacterium tuberculosis detection kits; veterinary diagnostics; food safety assays comprising foodborne pathogen detection kits, HALAL food testing kits, and meat species identification kits; and nucleic acid extraction assays, such as extraction kits, extraction buffers, lysis buffers, and gDNA extraction kits. The company was incorporated in 2010 and is based in Daejeon, South Korea.